Wong, Founder and CEO of HCW Biologics, stated, “In the third quarter 2024, the Company expanded our product portfolio and possible disease indications that may be treated with our immunotherapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback